GeoVax Labs, Inc. (GOVX)
Develops vaccine and cancer treatment candidates using proprietary platform technology.
$0.73-0.04%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-96.0%
The outlook
GOVX trades near its 52-week lows and sits below both its 50- and 200-day moving averages, reflecting weak recent momentum. Analyst coverage shows a wide gap: the average price target sits roughly 13x the current price, though this likely reflects limited analyst coverage and wide dispersion in views. Overall sentiment leans bearish based on current technicals.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Price targetAvg target +1276% vs current price
Market cap
$3.8M
52-wk high
$20.63
52-wk low
$0.64
50-day avg
$1.49
200-day avg
$4.47
Trailing P/E
—